Literature DB >> 18771733

Differential effects of Usp14 and Uch-L1 on the ubiquitin proteasome system and synaptic activity.

B J Walters1, S L Campbell, P C Chen, A P Taylor, D G Schroeder, L E Dobrunz, K Artavanis-Tsakonas, H L Ploegh, J A Wilson, G A Cox, S M Wilson.   

Abstract

The ubiquitin proteasome pathway has been implicated in the pathogenesis of many neurodegenerative diseases, and alterations in two different deubiquitinating enzymes, Uch-L1 and Usp14, result in neurological phenotypes in mice. We identified a new mutation in Uch-L1 and compared the roles of Uch-L1 and Usp14 in the ubiquitin proteasome system. Deficiencies in either Uch-L1 or Usp14 result in decreased levels of ubiquitin, suggesting that they both regulate ubiquitin stability in the nervous system. However, the effect of ubiquitin depletion on viability and onset of symptoms is more severe in the Usp14-deficient mice, and changes in hippocampal synaptic transmission were only observed in Usp14-deficient mice. In addition, while Usp14 appears to function at the proteasome, Uch-L1 deficiency resulted in up-regulation of lysosomal components, indicating that Uch-L1 and Usp14 may differentially affect the ubiquitin proteasome system and synaptic activity by regulating different pools of ubiquitin in the cell.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18771733      PMCID: PMC2734958          DOI: 10.1016/j.mcn.2008.07.028

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  39 in total

Review 1.  The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction.

Authors:  Michael H Glickman; Aaron Ciechanover
Journal:  Physiol Rev       Date:  2002-04       Impact factor: 37.312

2.  Chemistry-based functional proteomics reveals novel members of the deubiquitinating enzyme family.

Authors:  Anna Borodovsky; Huib Ovaa; Nagamalleswari Kolli; Tudeviin Gan-Erdene; Keith D Wilkinson; Hidde L Ploegh; Benedikt M Kessler
Journal:  Chem Biol       Date:  2002-10

Review 3.  Neurological disease: UPS stops delivering!

Authors:  Richard J Miller; Scott M Wilson
Journal:  Trends Pharmacol Sci       Date:  2003-01       Impact factor: 14.819

4.  Dysregulation of protein modification by ISG15 results in brain cell injury.

Authors:  Kenneth J Ritchie; Michael P Malakhov; Christopher J Hetherington; Liming Zhou; Marie-Terese Little; Oxana A Malakhova; Jack C Sipe; Stuart H Orkin; Dong-Er Zhang
Journal:  Genes Dev       Date:  2002-09-01       Impact factor: 11.361

5.  Editing of ubiquitin conjugates by an isopeptidase in the 26S proteasome.

Authors:  Y A Lam; W Xu; G N DeMartino; R E Cohen
Journal:  Nature       Date:  1997-02-20       Impact factor: 49.962

6.  Multiple associated proteins regulate proteasome structure and function.

Authors:  David S Leggett; John Hanna; Anna Borodovsky; Bernat Crosas; Marion Schmidt; Rohan T Baker; Thomas Walz; Hidde Ploegh; Daniel Finley
Journal:  Mol Cell       Date:  2002-09       Impact factor: 17.970

7.  The UCH-L1 gene encodes two opposing enzymatic activities that affect alpha-synuclein degradation and Parkinson's disease susceptibility.

Authors:  Yichin Liu; Lara Fallon; Hilal A Lashuel; Zhihua Liu; Peter T Lansbury
Journal:  Cell       Date:  2002-10-18       Impact factor: 41.582

8.  Ubiquitination-dependent mechanisms regulate synaptic growth and function.

Authors:  A DiAntonio; A P Haghighi; S L Portman; J D Lee; A M Amaranto; C S Goodman
Journal:  Nature       Date:  2001-07-26       Impact factor: 49.962

9.  Synaptic defects in ataxia mice result from a mutation in Usp14, encoding a ubiquitin-specific protease.

Authors:  Scott M Wilson; Bula Bhattacharyya; Rivka A Rachel; Vincenzo Coppola; Lino Tessarollo; Deborah B Householder; Colin F Fletcher; Richard J Miller; Neal G Copeland; Nancy A Jenkins
Journal:  Nat Genet       Date:  2002-10-07       Impact factor: 38.330

10.  A proteolytic pathway that recognizes ubiquitin as a degradation signal.

Authors:  E S Johnson; P C Ma; I M Ota; A Varshavsky
Journal:  J Biol Chem       Date:  1995-07-21       Impact factor: 5.157

View more
  43 in total

1.  Altered neurotransmitter release machinery in mice deficient for the deubiquitinating enzyme Usp14.

Authors:  Bula J Bhattacharyya; Scott M Wilson; Hosung Jung; Richard J Miller
Journal:  Am J Physiol Cell Physiol       Date:  2011-11-09       Impact factor: 4.249

2.  Ubiquitin homeostasis is critical for synaptic development and function.

Authors:  Ping-Chung Chen; Bula J Bhattacharyya; John Hanna; Heather Minkel; Julie A Wilson; Daniel Finley; Richard J Miller; Scott M Wilson
Journal:  J Neurosci       Date:  2011-11-30       Impact factor: 6.167

3.  Inhibition of Ubiquitin-Specific Protease 14 Suppresses Cell Proliferation and Synergizes with Chemotherapeutic Agents in Neuroblastoma.

Authors:  Yang Yu; Yanling Zhao; Yihui Fan; Zhenghu Chen; Hui Li; Jiaxiong Lu; Kevin Guo; Sarah E Woodfield; Sanjeev A Vasudevan; Jianhua Yang; Jed G Nuchtern
Journal:  Mol Cancer Ther       Date:  2019-04-08       Impact factor: 6.261

4.  Membrane-associated farnesylated UCH-L1 promotes alpha-synuclein neurotoxicity and is a therapeutic target for Parkinson's disease.

Authors:  Zhihua Liu; Robin K Meray; Tom N Grammatopoulos; Ross A Fredenburg; Mark R Cookson; Yichin Liu; Todd Logan; Peter T Lansbury
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-04       Impact factor: 11.205

5.  A catalytic independent function of the deubiquitinating enzyme USP14 regulates hippocampal synaptic short-term plasticity and vesicle number.

Authors:  Brandon J Walters; Jada J Hallengren; Christopher S Theile; Hidde L Ploegh; Scott M Wilson; Lynn E Dobrunz
Journal:  J Physiol       Date:  2013-11-11       Impact factor: 5.182

6.  Ubiquitin C-terminal hydrolase L1 (UCH-L1) loss causes neurodegeneration by altering protein turnover in the first postnatal weeks.

Authors:  Anna T Reinicke; Karoline Laban; Marlies Sachs; Vanessa Kraus; Michael Walden; Markus Damme; Wiebke Sachs; Julia Reichelt; Michaela Schweizer; Philipp Christoph Janiesch; Kent E Duncan; Paul Saftig; Markus M Rinschen; Fabio Morellini; Catherine Meyer-Schwesinger
Journal:  Proc Natl Acad Sci U S A       Date:  2019-03-28       Impact factor: 11.205

7.  Ubiquitin vinyl methyl ester binding orients the misaligned active site of the ubiquitin hydrolase UCHL1 into productive conformation.

Authors:  David A Boudreaux; Tushar K Maiti; Christopher W Davies; Chittaranjan Das
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-03       Impact factor: 11.205

8.  Parkin-mediated K63-polyubiquitination targets ubiquitin C-terminal hydrolase L1 for degradation by the autophagy-lysosome system.

Authors:  Jeanne E McKeon; Di Sha; Lian Li; Lih-Shen Chin
Journal:  Cell Mol Life Sci       Date:  2014-11-18       Impact factor: 9.261

9.  Ubiquitin carboxyl-terminal hydrolase L1 is required for maintaining the structure and function of the neuromuscular junction.

Authors:  Fujun Chen; Yoshie Sugiura; Kalisa Galina Myers; Yun Liu; Weichun Lin
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-04       Impact factor: 11.205

10.  The ataxia (axJ) mutation causes abnormal GABAA receptor turnover in mice.

Authors:  Corinna Lappe-Siefke; Sven Loebrich; Wulf Hevers; Oliver B Waidmann; Michaela Schweizer; Susanne Fehr; Jean-Marc Fritschy; Ivan Dikic; Jens Eilers; Scott M Wilson; Matthias Kneussel
Journal:  PLoS Genet       Date:  2009-09-04       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.